Bumper Offer - Urjas oil Just @ Rs. 1
Olanex 2.5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Schizophrenia. The alternative uses of Olanex 2.5 Tablet have also been explained below.
The correct dosage of Olanex 2.5 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Olanex 2.5 Tablet have been listed ahead. Normally, these side effects of Olanex 2.5 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Olanex 2.5 Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Olanex 2.5 Tablet related warnings talks about Olanex 2.5 Tablet's effects on the liver, heart and kidney.
Olanex 2.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Tardive Dyskinesia, Depression are examples of such conditions. Some other conditions that can be affected by Olanex 2.5 Tablet are listed in the contraindications section below.
Drug reaction of Olanex 2.5 Tablet with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Olanex 2.5 Tablet is considered not safe while driving, and is not addictive.
Olanex 2.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Olanex 2.5 Tablet safe for pregnant women?
Olanex can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Olanex right away. Take your doctor's advice before taking it again.
Is the use of Olanex 2.5 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Olanex. It should only be taken after medical advice.
What is the effect of Olanex 2.5 Tablet on the Kidneys?
Olanex does not damage the kidneys.
What is the effect of Olanex 2.5 Tablet on the Liver?
Very few cases of side effects of Olanex on the liver have been reported.
What is the effect of Olanex 2.5 Tablet on the Heart?
Olanex is rarely harmful for the heart.
Olanex 2.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Olanex 2.5 Tablet unless your doctor advises you to do so -
Is this Olanex 2.5 Tablet habit forming or addictive?
No, there is no any evidence that Olanex 2.5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olanex 2.5 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Olanex 2.5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, taking Olanex 2.5 Tablet can treat mental disorders.
Interaction between Food and Olanex 2.5 Tablet
When consumed with certain foods, Olanex 2.5 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Olanex 2.5 Tablet
Consuming Olanex 2.5 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
